Medicare Part D drug Data year 2024 Generic name Source: CMS Part D Prescribers

Mycophenolate Mofetil

Open in the dashboard

Part D claims

384,122

Prescriptions dispensed, refills included

Drug cost

$46,786,203

Paid at the pharmacy, in all

Prescribers

12,869

With 11 or more claims of it

In 2024, Medicare Part D recorded 384,122 claims for Mycophenolate Mofetil from 12,869 prescribers, at a total drug cost of $46.8 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 53 states and territories
Part D claims for Mycophenolate Mofetil by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 1,306 37,339 $4,951,754
TX 947 31,080 $3,491,262
NY 946 28,197 $3,727,480
FL 753 22,202 $2,583,663
PA 698 19,841 $2,639,184
OH 550 17,108 $2,104,078
NC 489 15,715 $1,734,725
MI 417 13,042 $1,843,137
IL 441 12,794 $1,508,957
GA 348 11,381 $1,399,030
MO 305 10,233 $1,145,174
MA 360 10,213 $1,348,862
MN 322 8,935 $933,565
LA 214 8,793 $911,317
WI 300 8,472 $965,359
The other 38 states and territories
State Prescribers Claims Drug cost
WA 273 8,409 $923,203
AZ 279 8,034 $996,229
VA 287 7,883 $1,090,303
TN 264 7,507 $975,413
IN 252 6,999 $835,812
AL 208 6,879 $804,847
NJ 245 6,179 $745,658
MD 230 6,170 $945,563
KY 192 6,079 $658,835
SC 208 5,812 $770,949
CO 212 5,723 $823,278
PR 132 5,401 $325,643
CT 168 4,742 $604,951
OR 179 4,710 $562,161
IA 138 4,064 $406,110
KS 109 3,447 $408,003
AR 111 3,444 $316,617
OK 93 3,431 $364,880
MS 90 2,955 $325,413
ID 82 2,035 $289,276
UT 84 1,921 $223,449
NE 72 1,903 $164,591
NV 62 1,867 $176,077
NM 60 1,634 $170,618
NH 52 1,310 $158,002
WV 47 1,272 $197,423
ME 49 1,161 $211,075
SD 43 1,155 $112,949
HI 35 1,075 $201,178
DE 27 1,049 $165,137
DC 42 978 $142,495
MT 40 922 $98,576
ND 34 850 $88,463
VT 23 723 $91,785
RI 36 649 $68,882
WY 8 226 $21,911
AK 6 167 $32,217
GU 1 12 $683

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 52
Part D claims for Mycophenolate Mofetil by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Rheumatology 3,056 107,830 $15,191,941
Neurology 1,572 44,614 $5,843,345
Nurse Practitioner 1,376 43,260 $4,885,702
Pulmonary Disease 1,147 37,441 $4,372,449
Internal Medicine 1,219 30,860 $3,618,136
Gastroenterology 515 23,452 $2,163,773
Nephrology 1,014 23,109 $2,300,337
Dermatology 865 18,988 $2,016,511
Physician Assistant 608 16,848 $1,911,145
Advanced Heart Failure and Transplant Cardiology 195 7,116 $793,422
Ophthalmology 149 5,714 $754,453
Family Practice 335 5,454 $611,424
Cardiology 143 4,623 $551,818
Critical Care (Intensivists) 168 4,591 $557,902
General Surgery 71 1,986 $206,245

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Rajiv Shah Ophthalmology NC 593 $82,010 None on record
Bernard Hojaili Internal Medicine LA 474 $56,394 None on record
Deepak Venkat Gastroenterology MI 439 $44,920 None on record
Noemi Varela Rosario Internal Medicine PR 437 $12,912 None on record
Adam Devore Advanced Heart Failure and Transplant Cardiology NC 396 $38,796 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for mycophenolate mofetil

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record